한글목차

심혈관 중재시술 기기 세계 시장은 2030년까지 264억 달러에 달할 것으로 예상

2023년 168억 달러로 추정되는 심혈관 중재시술 기기 세계 시장은 2030년에는 264억 달러에 달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 6.7%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 혈관성형술용 풍선은 CAGR 7.2%를 기록하여 분석 기간 종료 시점에 73억 달러에 도달할 것으로 예상됩니다. 혈관 성형술용 스텐트 부문은 분석 기간 동안 CAGR 7.2%의 성장률을 나타낼 것으로 추정됩니다.

미국 시장은 약 45억 달러, 중국은 CAGR 11.2%로 성장할 것으로 예상

미국의 심혈관 중재시술 기기 시장은 2023년 45억 달러에 달할 것으로 추정됩니다. 세계 2위 경제 대국인 중국은 2023-2030년의 분석 기간 동안 11.2%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 65억 달러 규모에 이를 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.7%와 6.5%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 3.4%의 성장률을 보일 것으로 예상됩니다.

세계 심혈관 중재시술 기기 시장 - 주요 동향 및 촉진요인 요약

기술 혁신은 심혈관 중재시술 기기 시장에 어떤 영향을 미치고 있는가?

기술 혁신은 심혈관 중재시술 기기 시장의 주요 원동력이며, 환자 예후와 시술 효율을 개선하는 첨단 기기 시장 개척으로 이어지고 있습니다. 생체 흡수성 스텐트 및 약물 용출 스텐트 도입 등 최근 스텐트 기술의 발전으로 기존 금속 스텐트에서 발생하는 합병증이 크게 감소했습니다. 또한, 혈관 내 초음파(IVUS), 빛 간섭 단층촬영(OCT) 등 영상 기술의 혁신으로 시술 중 통찰력이 더욱 명확해져 심장 전문의가 보다 정확한 판단을 내릴 수 있게 되었습니다. 로봇공학과 인공지능을 중재적 심장학에 통합하는 사례도 증가하고 있으며, 정밀하고 최소침습적인 시술을 용이하게 함으로써 회복 시간을 단축하고 환자의 편안함을 향상시키고 있습니다. 이러한 기술의 지속적인 발전은 심혈관 질환의 진단과 치료에 새로운 가능성을 제공함으로써 시장의 성장과 변화를 촉진할 것으로 기대됩니다.

심혈관 질환의 유병률 증가가 시장 수요를 촉진하는 이유는 무엇인가?

심혈관 질환(CVD)의 유병률 증가는 심혈관 중재시술 기기에 대한 수요를 촉진하는 중요한 요인입니다. 관상동맥질환, 심장마비, 뇌졸중과 같은 CVD는 고령화, 건강하지 못한 생활습관, 비만, 흡연 등의 요인으로 인해 여전히 전 세계 사망 원인 중 가장 높은 비중을 차지하고 있습니다. 이러한 질병 부담 증가로 인해 조기 회복, 입원 기간 단축, 의료비 절감을 위한 최소침습적 치료법에 대한 수요가 증가하고 있습니다. 혈관성형술, 스텐트삽입술, 동맥절제술과 같은 중재적 심장학 시술은 기존 수술적 시술에 대한 효과적인 대안으로 각광받고 있습니다. 이러한 최소침습적 솔루션에 대한 수요 증가는 첨단 심혈관 중재시술 기기의 채택을 촉진하고 시장 성장을 가속하고 있습니다.

향후 성장 전망을 형성하는 신흥 시장의 역할은 무엇인가?

이머징 마켓은 심혈관 중재시술 기기 시장의 향후 성장 전망을 형성하는 데 중요한 역할을 하고 있습니다. 아시아태평양, 라틴아메리카 및 중동 국가들은 의료 인프라의 급속한 성장, 의료비 지출 증가, 의료 서비스 접근성 향상으로 의료 인프라가 빠르게 성장하고 있습니다. 또한 이 지역에서는 도시화, 라이프스타일의 변화, 평균 수명 증가로 인해 심혈관 질환의 유병률이 증가하고 있어 첨단 심혈관 중재시술 기기에 대한 수요가 크게 증가하고 있습니다. 이들 시장의 정부도 의료 개혁에 적극적으로 투자하고 있으며, 전문 심장학 서비스 강화에 집중하고 있습니다. 또한 저침습적 시술에 대한 인식이 높아지고 많은 환자 풀이 존재하기 때문에 시장 참여자들이 성장률이 높은 지역에 진출할 수 있는 좋은 기회를 제공합니다.

심혈관 중재시술 기기 시장의 성장은 어떤 요인에 의해 이루어지고 있는가?

심혈관 중재시술 기기 시장의 성장은 심혈관 질환의 유병률 증가, 기기 기술 발전, 신흥 시장에서의 의료 인프라 확대 등 여러 요인에 의해 주도되고 있습니다. 약물 용출성 스텐트, 생체 흡수성 혈관 비계, 차세대 영상 시스템과 같은 혁신적인 기기의 지속적인 개발로 중재적 시술의 효과와 안전성이 향상되어 의료 서비스 제공업체 사이에서 채택률이 증가하고 있습니다. 또한 저침습적 치료에 대한 환자들의 인식과 선호도가 높아짐에 따라 심혈관 중재시술 기기에 대한 수요가 증가하고 있습니다. 또한, 세계 인구의 고령화와 고혈압, 당뇨병과 같은 위험 요소의 유병률 증가는 시장 성장에 더욱 기여하고 있습니다. 신흥국들이 의료 현대화에 투자하고 고급 심장학 서비스에 대한 접근성을 확대함에 따라 심혈관 중재시술 기기 시장은 향후 몇 년동안 강력한 성장세를 보일 것으로 예상됩니다.

조사 대상 기업 예시(총 22건)

• Abbott Laboratories
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Cook Medical, Inc.
• Johnson & Johnson
• Medtronic, Inc.
• Smiths Medical
• Terumo Corporation

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 호주
• 인도
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 아르헨티나
• 브라질
• 멕시코
• 기타 라틴아메리카
• 중동
• 이란
• 이스라엘
• 사우디아라비아
• 아랍에미리트(UAE)
• 기타 중동
• 아프리카

제4장 경쟁

영문목차

Global Interventional Cardiology Devices Market to Reach US$26.4 Billion by 2030

The global market for Interventional Cardiology Devices estimated at US$16.8 Billion in the year 2023, is expected to reach US$26.4 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Angioplasty Balloons, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$7.3 Billion by the end of the analysis period. Growth in the Angioplasty Stents segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.5 Billion While China is Forecast to Grow at 11.2% CAGR

The Interventional Cardiology Devices market in the U.S. is estimated at US$4.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Interventional Cardiology Devices Market - Key Trends & Drivers Summarized

How Are Technological Innovations Impacting the Interventional Cardiology Devices Market?

Technological innovations have been a major driving force in the interventional cardiology devices market, leading to the development of advanced devices that improve patient outcomes and procedural efficiency. Recent advancements in stent technology, such as the introduction of bioresorbable stents and drug-eluting stents, have significantly reduced complications associated with traditional metal stents. Furthermore, innovations in imaging technologies, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are providing clearer insights during procedures, enabling cardiologists to make more accurate decisions. The integration of robotics and artificial intelligence into interventional cardiology is also on the rise, facilitating precise and minimally invasive procedures, which reduce recovery times and enhance patient comfort. As these technologies continue to evolve, they are expected to drive further growth and transformation in the market, offering new possibilities for the diagnosis and treatment of cardiovascular diseases.

Why Is the Growing Prevalence of Cardiovascular Diseases Fueling Market Demand?

The growing prevalence of cardiovascular diseases (CVDs) is a critical factor fueling the demand for interventional cardiology devices. CVDs, including coronary artery disease, heart attacks, and stroke, remain the leading cause of mortality worldwide, driven by factors such as aging populations, unhealthy lifestyles, obesity, and smoking. The increasing burden of these diseases has led to a higher demand for minimally invasive procedures that offer quicker recovery, reduced hospital stays, and lower healthcare costs. Interventional cardiology procedures, such as angioplasty, stenting, and atherectomy, are becoming more common as they provide effective alternatives to traditional surgical methods. This rising demand for minimally invasive solutions is driving the adoption of advanced interventional cardiology devices, thereby boosting market growth.

What Role Do Emerging Markets Play in Shaping Future Growth Prospects?

Emerging markets are playing a significant role in shaping the future growth prospects of the interventional cardiology devices market. Countries in Asia-Pacific, Latin America, and the Middle East are experiencing rapid growth in healthcare infrastructure, increased healthcare spending, and improved access to medical services. Additionally, the rising prevalence of cardiovascular diseases in these regions, due to urbanization, lifestyle changes, and increased life expectancy, is creating substantial demand for advanced interventional cardiology devices. Governments in these markets are also actively investing in healthcare reforms and are focusing on enhancing the availability of specialized cardiology services. Moreover, the growing awareness about minimally invasive procedures and the presence of a large patient pool present lucrative opportunities for market players to expand their footprint and tap into these high-growth regions.

How Is the Growth in the Interventional Cardiology Devices Market Driven by Several Factors?

The growth in the interventional cardiology devices market is driven by several factors, including the increasing prevalence of cardiovascular diseases, advancements in device technology, and the expansion of healthcare infrastructure in emerging markets. The continuous development of innovative devices, such as drug-eluting stents, bioresorbable vascular scaffolds, and next-generation imaging systems, is enhancing the effectiveness and safety of interventional procedures, driving higher adoption among healthcare providers. The rising awareness and preference for minimally invasive procedures among patients are also boosting the demand for interventional cardiology devices. Additionally, the aging global population and the growing incidence of risk factors like hypertension and diabetes are further contributing to market growth. As emerging economies invest in healthcare modernization and expand access to advanced cardiology services, the market for interventional cardiology devices is set to experience robust growth in the coming years.

Select Competitors (Total 22 Featured) -

• Abbott Laboratories
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Cook Medical, Inc.
• Johnson & Johnson
• Medtronic, Inc.
• Smiths Medical
• Terumo Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Interventional Cardiology Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Adoption of Minimally Invasive Procedures Driving Market Growth
  • Technological Advancements in Stent Designs Enhancing Patient Outcomes
  • Rising Prevalence of Cardiovascular Diseases Boosting Demand for Cardiology Devices
  • Growing Preference for Drug-Eluting Balloons Over Traditional Stents
  • Development of Bioabsorbable Stents as a Sustainable Alternative
  • Integration of Imaging Technologies in Interventional Devices Improving Precision
  • Expanding Geriatric Population Base Leading to Higher Procedure Volumes
  • Growing Investments in R&D Leading to Innovative Device Launches
  • Surge in Demand for Hybrid Operating Rooms Enhancing Surgical Capabilities
  • Regulatory Approvals and Favorable Reimbursement Policies Driving Market Adoption
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Interventional Cardiology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Interventional Cardiology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Angioplasty Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Angioplasty Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Structural Heart Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Structural Heart Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Structural Heart Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Plaque Modification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Hemodynamic Flow Alteration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• JAPAN
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• CHINA
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 35: China Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: China Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: China 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• EUROPE
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 38: Europe Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 39: Europe Historic Review for Interventional Cardiology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Europe 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 41: Europe Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Europe Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Europe 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• FRANCE
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 44: France Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: France Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: France 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• GERMANY
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 47: Germany Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Germany Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Germany 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 50: Italy Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Italy Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Italy 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 53: UK Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: UK Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: UK 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 56: Spain Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Spain Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Spain 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 59: Russia Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Russia Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Russia 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Rest of Europe Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Rest of Europe 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 65: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 66: Asia-Pacific Historic Review for Interventional Cardiology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Asia-Pacific 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Asia-Pacific Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: Asia-Pacific 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 71: Australia Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Australia Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: Australia 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• INDIA
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 74: India Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: India Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: India 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 77: South Korea Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: South Korea Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: South Korea 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 80: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Rest of Asia-Pacific Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Rest of Asia-Pacific 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 83: Latin America Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 84: Latin America Historic Review for Interventional Cardiology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Latin America 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 86: Latin America Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Latin America Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Latin America 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 89: Argentina Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Argentina Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Argentina 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 92: Brazil Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Brazil Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Brazil 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 95: Mexico Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Mexico Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Mexico 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 98: Rest of Latin America Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Rest of Latin America Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Rest of Latin America 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 101: Middle East Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 102: Middle East Historic Review for Interventional Cardiology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Middle East 16-Year Perspective for Interventional Cardiology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 104: Middle East Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Middle East Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 106: Middle East 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 107: Iran Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Iran Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 109: Iran 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 110: Israel Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 111: Israel Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 112: Israel 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 113: Saudi Arabia Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 114: Saudi Arabia Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 115: Saudi Arabia 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 116: UAE Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 117: UAE Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 118: UAE 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 119: Rest of Middle East Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 120: Rest of Middle East Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 121: Rest of Middle East 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030
• AFRICA
  • Interventional Cardiology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 122: Africa Recent Past, Current & Future Analysis for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 123: Africa Historic Review for Interventional Cardiology Devices by Device Type - Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 124: Africa 16-Year Perspective for Interventional Cardiology Devices by Device Type - Percentage Breakdown of Value Sales for Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices and Other Device Types for the Years 2014, 2024 & 2030

IV. COMPETITION